Aspen Pharmacare Holdings Stock Forecast for 2023 - 2025 - 2030
Updated on 03/28/2024
Aspen Pharmacare Holdings Stock Forecast and Price Target
The average price target for Aspen Pharmacare Holdings's stock set by recognized analysts recently is R219.00, which would result in a potential upside of approximately 6.36% if it reached this mark. The estimation is based on a high estimate of R233.27 and a low estimate of R211.00. If you are looking to invest in the stock, it's important to research and compare different companies.
6.36% Upside
Aspen Pharmacare Holdings Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Aspen Pharmacare Holdings's Price has seen a drop from R159.10 to R0.00 – a 100.00% decrease. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach R171.59 – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for Aspen Pharmacare Holdings will be 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
SUNPHARMA Stock Forecast | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.59k | Buy/Sell | Rp1.52k | -1.42% |
TEVA Stock Forecast | Teva Pharmaceutical Industries | Outperform |
12
|
$13.35 | Buy/Sell | $11.59 | 19.85% |
VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.97 | Buy/Sell | $11.73 | 0.25% |
SHP Stock Forecast | Shoprite Holdings Ltd | Hold |
18
|
R268.84 | Buy/Sell | R267.29 | 4.15% |
HIK Stock Forecast | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.10 | Buy/Sell | £28.11 | 55.34% |
Aspen Pharmacare Holdings Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Revenue for Aspen Pharmacare Holdings has grown by 5.34%, going from R38.65B to R40.71B. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach R44.82B – an increase of 10.11%. Over the next seven years, experts anticipate that Revenue growth for Aspen Pharmacare Holdings will be 21.50%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
RICHTER Stock Forecast | Outperform |
18
|
Ft9.66k | Buy/Sell | Ft11.02k | 20.86% | |
KRKG Stock Forecast | Krka, d. d. | Buy |
18
|
123.00€ | Buy/Sell | 119.80€ | 15.85% |
PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$30.59 | Buy/Sell | $44.75 | 27.49% |
Aspen Pharmacare Holdings Dividend per Share Forecast for 2023 - 2025 - 2030
Aspen Pharmacare Holdings's Dividend per Share has grown in the last two years, jumping from R2.62 to R3.42 – an increase of 30.53%. In the next year, analysts predict that Dividend per Share will reach R3.61 – an increase of 5.56%. For the next seven years, the forecast is for Dividend per Share to grow by 31.49%.
Aspen Pharmacare Holdings EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Aspen Pharmacare Holdings's EBITDA has decreased from R10.43B to R10.19B – a 2.31% drop. For next year, the 5 analysts predict EBITDA of R11.61B, which would mean an increase of 13.92%. Over the next seven years, the pros' prediction is EBITDAof R13.24B, which would mean a seven-year growth forecast of 29.97%.
Aspen Pharmacare Holdings EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Aspen Pharmacare Holdings's EBIT has decreased by 4.75%, going from R9.37B to R8.93B. In the next year, analysts expect EBIT to reach R9.64B – an increase of 7.99%. For the next eight years, the forecast is for EBIT to grow by 26.76%.
Aspen Pharmacare Holdings EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Aspen Pharmacare Holdings's EPS has seen a drop from R14.65 to R0.00 – a 100.00% decrease. In the coming year, analysts are expecting an increase in EPS, predicting it will reach R15.80 – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for Aspen Pharmacare Holdings will be 100.00%.